Hino Minako, Yamashiro Yasuhiro, Hattori Yukio, Ito Hitomi, Nitta Takenori, Adhiyanto Chris, Matar Maryam, Naveed Mohammed
Yamaguchi University Graduate School of Medicine, Ube, Japan.
Hemoglobin. 2012;36(2):170-6. doi: 10.3109/03630269.2011.647186. Epub 2012 Jan 4.
β-Thalassemia (β-thal) is characterized by the absent or reduced production of β-globin chains. The precise molecular lesion that causes decreased β-globin synthesis in β(+)-thal is difficult to predict when mutations occur in the locus control region (LCR), the promoter, the introns or 3' untranslated regions (3'UTRs). Among them, the role of the 3'UTR of β-globin gene in mRNA stability is poorly understood, mainly due to very few cases that have mutations in this region. So far, only three mutations have been reported in the 3'UTR of β-globin gene. Although, it is speculated that some of these reported mutations could be associated with mRNA stability, the precise molecular basis still remains unclear. We report here a novel mutation in the β-globin gene 3'UTR [+1,506 (A>C)] in a 31-year-old Japanese male with hematological parameters suggestive of heterozygous β-thal. Further functional studies on this novel mutation reported here, may help in understanding of the regulation and expression of the β-globin gene and its products.
β地中海贫血(β-thal)的特征是β珠蛋白链生成缺失或减少。当β(+)-地中海贫血中β珠蛋白合成减少的精确分子病变发生在位点控制区(LCR)、启动子、内含子或3'非翻译区(3'UTR)时,很难预测。其中,β珠蛋白基因3'UTR在mRNA稳定性中的作用了解甚少,主要是因为该区域发生突变的病例极少。到目前为止,β珠蛋白基因3'UTR仅报道了三种突变。尽管据推测,这些报道的一些突变可能与mRNA稳定性有关,但其精确的分子基础仍不清楚。我们在此报告一名31岁日本男性β珠蛋白基因3'UTR [+1,506(A>C)]中的一种新突变,其血液学参数提示为杂合子β地中海贫血。对本文报道的这种新突变进行进一步的功能研究,可能有助于理解β珠蛋白基因及其产物的调控和表达。